PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsEstrone
Estrone
Estrogenic Substance, Theelin (estrone) is a small molecule pharmaceutical. Estrone was first approved as Theelin on 1982-01-01. It is used to treat breast neoplasms, hot flashes, hypogonadism, menorrhagia, and premature menopause amongst others in the USA. The pharmaceutical is active against estrogen receptor. In addition, it is known to target solute carrier organic anion transporter family member 1A2, solute carrier organic anion transporter family member 1C1, solute carrier organic anion transporter family member 2B1, solute carrier organic anion transporter family member 4A1, estrogen receptor beta, solute carrier organic anion transporter family member 3A1, and solute carrier organic anion transporter family member 1B1.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
endocrine system diseasesD004700
signs and symptoms pathological conditionsD013568
reproductive and urinary physiological phenomenaD012101
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Estrone
Tradename
Company
Number
Date
Products
THEELINParkedale PharmaceuticalsN-003977 DISCN1982-01-01
3 products
Hide discontinued
Labels
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
G: Genito urinary system and sex hormones
— G03: Sex hormones and modulators of the genital system
— G03C: Estrogens, sex hormones and modulators of the genital system
— G03CA: Natural and semisynthetic estrogens, plain
— G03CA07: Estrone
— G03CC: Estrogens, combinations with other drugs
— G03CC04: Estrone
HCPCS
Code
Description
J1435
Injection, estrone, per 1 mg
Clinical
Clinical Trials
763 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfertilityD007246EFO_0000545—2429476999257
Female infertilityD007247EFO_0008560N97126783160
ContraceptionD003267——891815554
Polycystic ovary syndromeD011085EFO_0000660E28.233772847
SyndromeD013577——36762344
Healthy volunteers/patients———33141442
Fertilization in vitroD005307——133121028
Ovulation inductionD010062——3754624
Primary ovarian insufficiencyD016649EFO_0004266E28.354211120
Breast neoplasmsD001943EFO_0003869C504421817
Show 53 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
EndometriosisD004715EFO_0001065N80212—1317
PregnancyD011247EFO_0002950Z33.1——1—1011
NeoplasmsD009369—C80511—28
LymphomaD008223—C85.9341—28
Thyroid diseasesD013959—E00-E07142——7
Pituitary diseasesD010900—E23.7—13—37
Premenstrual syndromeD011293—N94.3—24—17
Thyroid neoplasmsD013964EFO_0003841——42——6
Male infertilityD007248EFO_0004248N46—11—45
Prostatic neoplasmsD011471—C61211—14
Show 25 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ovarian reserveD065851EFO_0004770——1——56
MetrorrhagiaD008796—N92.1—3——14
Papillary thyroid cancerD000077273———3———3
Follicular adenocarcinomaD018263———3———3
LeiomyomaD007889—D2511——23
CarcinomaD002277—C80.013———3
HemostasisD006487———1——12
Non-hodgkin lymphomaD008228—C85.9—2———2
Ovarian diseasesD010049———1——12
Hodgkin diseaseD006689—C8112———2
Show 34 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Therapeutic equivalencyD013810——9————9
PharmacokineticsD010599——5————5
Diabetes mellitusD003920EFO_0000400E08-E131———34
Drug interactionsD004347——4————4
HivD006678—O98.71———23
Type 2 diabetes mellitusD003924EFO_0001360E113————3
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.813————3
FibrosisD005355——2———13
Cystic fibrosisD003550EFO_0000390E842———13
OverweightD050177—E66.32———13
Show 28 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Menstrual cycleD008597——————66
Covid-19D000086382—U07.1————66
FertilityD005298——————55
Ovarian cystsD010048—N83.1————33
Metabolic syndromeD024821EFO_0000195E88.810————33
Type 1 diabetes mellitusD003922EFO_0001359E10————33
Oxidative stressD018384EFO_1001905—————33
SclerosisD012598——————22
In vitro oocyte maturation techniquesD059471——————22
Endocrine system diseasesD004700EFO_0001379E34.9————22
Show 116 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameEstrone
INNestrone
Description
Estrone is a 17-oxo steroid that is estra-1,3,5(10)-triene substituted by an hydroxy group at position 3 and an oxo group at position 17. It has a role as an estrogen, a bone density conservation agent, an antineoplastic agent, a human metabolite and a mouse metabolite. It is a 3-hydroxy steroid, a phenolic steroid, a member of phenols and a 17-oxo steroid. It derives from a hydride of an estrane.
Classification
Small molecule
Drug classestrogens
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O
Identifiers
PDB—
CAS-ID53-16-7
RxCUI—
ChEMBL IDCHEMBL1405
ChEBI ID17263
PubChem CID5870
DrugBankDB00655
UNII ID2DI9HA706A (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
ESR2
ESR2
SLCO2B1
SLCO2B1
SLCO3A1
SLCO3A1
Organism
Homo sapiens
Gene name
ESR2
Gene synonyms
ESTRB, NR3A2
NCBI Gene ID
Protein name
estrogen receptor beta
Protein synonyms
estrogen receptor beta 2, estrogen receptor beta 4, Nuclear receptor subfamily 3 group A member 2, oestrogen receptor beta
Uniprot ID
Mouse ortholog
Esr2 (13983)
estrogen receptor beta (O08537)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Estrone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 19,597 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
352 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use